Table 1.

Patient demographic information and illness history.

Case	Age range	Illness duration (years)	Diagnosis	ATHF (cumulative score)	Baseline meds	Med changes
1	31–35	16	SCZ	3	Clozapine, Clonzepam	No change
2	56–59	44	SCZ	8	Risperidone, Clonazepam, Venlafaxine	No change
3	51–55	39	SCZ	16	Lorazepam, Atorvastatin, Levothyroxine, Olanzapine	No change
4	51–55	25	SCZ-A	18	Lithium, Lorazepam, Lamotrigine, Valproic acid, Quetiapine, Pantoprazole, Risperidone, Levothyroxine	T3: D/C Lithium, Lorazepam, Lamotrigine, Valproic Acid
5	41–45	23	SCZ	26	Lurasidone	T1: Added Amisulpride, Zopiclone, D/C Lurasidone
6	26–30	11	SCZ	5	Clozapine, Paliperidone, Valproic acid	T3: D/C Valproic acid
7	36–40	16	SCZ	18	Clozapine, Escitalopram, Atenolol, Rosuvastatin, Metformin, Pantoprazole, Sennosides, Clonazepam	T23: Decreased escitalopram
8	60–65	25	SCZ-A	6	Clozapine, Vitamin B Complex, Calcium Carbonate, Vitamin D, Clopidogrel, Coenzyme Q10, Dexlansoprazole, Multivitamin, Levothyroxine, Linaclotide, Magnesium citrate, Alirocumab	T18: Increased dexlansoprazole

SCZ, schizophrenia; SCZ-A, schizoaffective; ATHF, antidepressant treatment history form (modified for antipsychotics), cumulative score for current episode; medication changes at time of treatment (for example, T3 = Treatment 3). D/C, discontinued.